(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:732984 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATP2B1 mRNA CTD PMID:22079256 1,2-dimethylhydrazine multiple interactions ISO RGD:621303 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in increased expression of ATP2B1 mRNA CTD PMID:27840820 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of ATP2B1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of ATP2B1 mRNA, Ethinyl Estradiol results in decreased expression of ATP2B1 protein CTD PMID:27690074 17alpha-ethynylestradiol decreases expression ISO RGD:621303 6480464 Ethinyl Estradiol results in decreased expression of ATP2B1 mRNA CTD PMID:15834898 , PMID:17557909 17beta-estradiol multiple interactions ISO RGD:732984 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ATP2B1 mRNA, EGF protein inhibits the reaction [Estradiol results in decreased expression of ATP2B1 mRNA] CTD PMID:20823114 , PMID:24758408 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ATP2B1 mRNA CTD PMID:30061528 17beta-estradiol decreases expression ISO RGD:732984 6480464 Estradiol results in decreased expression of ATP2B1 mRNA CTD PMID:21185374 , PMID:24758408 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of ATP2B1 mRNA CTD PMID:16214954 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732984 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATP2B1 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:621303 6480464 Tetrachlorodibenzodioxin affects the expression of ATP2B1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP2B1 mRNA CTD PMID:19770486 2,3-dimethoxynaphthalene-1,4-dione decreases expression ISO RGD:732984 6480464 2 more ... CTD PMID:17547211 2,6-dinitrotoluene affects expression ISO RGD:621303 6480464 2, 6-dinitrotoluene affects the expression of ATP2B1 mRNA CTD PMID:21346803 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of ATP2B1 mRNA CTD PMID:26251327 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid decreases expression ISO RGD:732984 6480464 Am 580 results in decreased expression of ATP2B1 mRNA CTD PMID:16982809 4-tert-Octylphenol increases expression ISO RGD:621303 6480464 4-tert-octylphenol results in increased expression of ATP2B1 mRNA CTD PMID:17011747 5-azacytidine decreases expression ISO RGD:732984 6480464 Azacitidine results in decreased expression of ATP2B1 mRNA CTD PMID:20823114 6-propyl-2-thiouracil decreases expression ISO RGD:621303 6480464 Propylthiouracil results in decreased expression of ATP2B1 mRNA CTD PMID:24780913 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of ATP2B1 mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:732984 6480464 Tretinoin results in decreased expression of ATP2B1 mRNA CTD PMID:15498508 aminoguanidine decreases expression ISO RGD:621303 6480464 pimagedine results in decreased expression of ATP2B1 mRNA CTD PMID:15003327 antimony(0) decreases expression ISO RGD:732984 6480464 Antimony results in decreased expression of ATP2B1 mRNA CTD PMID:17547211 antirheumatic drug decreases expression ISO RGD:732984 6480464 Antirheumatic Agents results in decreased expression of ATP2B1 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ATP2B1 mRNA CTD PMID:23650126 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of ATP2B1 mRNA CTD PMID:19654921 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of ATP2B1 mRNA CTD PMID:19654921 arsenite(3-) affects expression ISO RGD:732984 6480464 arsenite affects the expression of ATP2B1 mRNA CTD PMID:22959463 arsenous acid decreases expression ISO RGD:732984 6480464 Arsenic Trioxide results in decreased expression of ATP2B1 mRNA CTD PMID:12852829 , PMID:17547211 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of ATP2B1 mRNA CTD PMID:26476475 atrazine affects expression EXP 6480464 Atrazine affects the expression of ATP2B1 mRNA CTD PMID:27112537 atrazine multiple interactions EXP 6480464 Lycopene inhibits the reaction [Atrazine affects the expression of ATP2B1 mRNA], Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP2B1 mRNA] CTD PMID:26476475 , PMID:27112537 benzo[a]pyrene decreases expression ISO RGD:621303 6480464 Benzo(a)pyrene results in decreased expression of ATP2B1 mRNA CTD PMID:21839799 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of ATP2B1 mRNA CTD PMID:27195522 benzo[a]pyrene affects expression EXP 6480464 Benzo(a)pyrene affects the expression of ATP2B1 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:732984 6480464 Benzo(a)pyrene results in decreased expression of ATP2B1 mRNA CTD PMID:20064835 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:732984 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 bisphenol A increases expression ISO RGD:621303 6480464 bisphenol A results in increased expression of ATP2B1 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [Streptozocin co-treated with bisphenol A] results in increased expression of ATP2B1 mRNA CTD PMID:29935216 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATP2B1 mRNA, bisphenol A results in decreased expression of ATP2B1 protein CTD PMID:27690074 bucladesine multiple interactions ISO RGD:732984 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ATP2B1 mRNA CTD PMID:20823114 cadmium atom decreases expression ISO RGD:732984 6480464 Cadmium results in decreased expression of ATP2B1 mRNA CTD PMID:17547211 cadmium dichloride decreases expression ISO RGD:732984 6480464 Cadmium Chloride results in decreased expression of ATP2B1 mRNA CTD PMID:17547211 calcitriol increases expression ISO RGD:621303 6480464 Calcitriol results in increased expression of ATP2B1 mRNA CTD PMID:10927029 calcitriol increases expression ISO RGD:732984 6480464 Calcitriol results in increased expression of ATP2B1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:732984 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ATP2B1 mRNA CTD PMID:21592394 calcium atom multiple interactions ISO RGD:732984 6480464 caloxin 1b1 inhibits the reaction [ATP2B1 protein results in increased export of Calcium] CTD PMID:16452157 calcium atom increases export ISO RGD:732984 6480464 ATP2B1 protein results in increased export of Calcium CTD PMID:16452157 calcium(0) multiple interactions ISO RGD:732984 6480464 caloxin 1b1 inhibits the reaction [ATP2B1 protein results in increased export of Calcium] CTD PMID:16452157 calcium(0) increases export ISO RGD:732984 6480464 ATP2B1 protein results in increased export of Calcium CTD PMID:16452157 chromium atom decreases expression ISO RGD:732984 6480464 Chromium results in decreased expression of ATP2B1 mRNA CTD PMID:17547211 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of ATP2B1 mRNA CTD PMID:28472532 cisplatin increases expression ISO RGD:732984 6480464 Cisplatin results in increased expression of ATP2B1 mRNA CTD PMID:27594783 cisplatin decreases expression ISO RGD:732984 6480464 Cisplatin results in decreased expression of ATP2B1 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:732984 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of ATP2B1 mRNA CTD PMID:27392435 coumestrol multiple interactions ISO RGD:732984 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2B1 mRNA CTD PMID:19167446 coumestrol decreases expression ISO RGD:732984 6480464 Coumestrol results in decreased expression of ATP2B1 mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:732984 6480464 Asbestos, Crocidolite results in decreased expression of ATP2B1 mRNA CTD PMID:29523930 cyclosporin A increases expression ISO RGD:732984 6480464 Cyclosporine results in increased expression of ATP2B1 mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:732984 6480464 Cyclosporine results in decreased expression of ATP2B1 mRNA CTD PMID:25562108 cyclosporin A decreases expression ISO RGD:621303 6480464 Cyclosporine results in decreased expression of ATP2B1 mRNA CTD PMID:21865292 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP2B1 mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO RGD:732984 6480464 Arsenic Trioxide results in decreased expression of ATP2B1 mRNA CTD PMID:12852829 , PMID:17547211 diazinon increases expression ISO RGD:621303 6480464 Diazinon results in increased expression of ATP2B1 mRNA CTD PMID:29108742 dibutyl phthalate increases expression ISO RGD:621303 6480464 Dibutyl Phthalate results in increased expression of ATP2B1 mRNA CTD PMID:21266533 diethylstilbestrol decreases expression ISO RGD:621303 6480464 Diethylstilbestrol results in decreased expression of ATP2B1 mRNA CTD PMID:17011747 diethylstilbestrol increases expression ISO RGD:621303 6480464 Diethylstilbestrol results in increased expression of ATP2B1 mRNA CTD PMID:17011747 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate decreases expression ISO RGD:732984 6480464 Antimony Potassium Tartrate results in decreased expression of ATP2B1 mRNA CTD PMID:17547211 disulfiram decreases expression ISO RGD:621303 6480464 Disulfiram results in decreased expression of ATP2B1 mRNA CTD PMID:15003327 diuron decreases expression ISO RGD:621303 6480464 Diuron results in decreased expression of ATP2B1 mRNA CTD PMID:25152437 Enterolactone multiple interactions ISO RGD:732984 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2B1 mRNA CTD PMID:19167446 ethanol affects expression ISO RGD:621303 6480464 Ethanol affects the expression of ATP2B1 mRNA CTD PMID:11772933 ethanol multiple interactions EXP 6480464 Ethanol affects the expression of and affects the splicing of ATP2B1 mRNA CTD PMID:30319688 gentamycin increases expression ISO RGD:621303 6480464 Gentamicins results in increased expression of ATP2B1 mRNA CTD PMID:22061828 gold atom multiple interactions EXP 6480464 [Gold co-treated with Polyethylene Glycols] results in decreased expression of ATP2B1 mRNA CTD PMID:19695318 gold(0) multiple interactions EXP 6480464 [Gold co-treated with Polyethylene Glycols] results in decreased expression of ATP2B1 mRNA CTD PMID:19695318 irinotecan affects expression ISO RGD:621303 6480464 Irinotecan affects the expression of ATP2B1 mRNA CTD PMID:20097248 isoflavones increases expression ISO RGD:732984 6480464 Isoflavones results in increased expression of ATP2B1 mRNA CTD PMID:17374662 lycopene multiple interactions EXP 6480464 Lycopene inhibits the reaction [Atrazine affects the expression of ATP2B1 mRNA], Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP2B1 mRNA] CTD PMID:26476475 , PMID:27112537 medroxyprogesterone acetate multiple interactions ISO RGD:732984 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ATP2B1 mRNA CTD PMID:20823114 melphalan decreases expression ISO RGD:732984 6480464 Melphalan results in decreased expression of ATP2B1 mRNA CTD PMID:22363485 methyl methanesulfonate decreases expression ISO RGD:732984 6480464 Methyl Methanesulfonate results in decreased expression of ATP2B1 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:732984 6480464 methylmercuric chloride results in decreased expression of ATP2B1 mRNA CTD PMID:28001369 miconazole decreases expression EXP 6480464 Miconazole results in decreased expression of ATP2B1 mRNA CTD PMID:27462272 N-methyl-4-phenylpyridinium decreases expression ISO RGD:732984 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ATP2B1 mRNA CTD PMID:24810058 N-nitrosodimethylamine decreases expression ISO RGD:732984 6480464 Dimethylnitrosamine results in decreased expression of ATP2B1 mRNA CTD PMID:17547211 oxaliplatin multiple interactions ISO RGD:621303 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ATP2B1 mRNA CTD PMID:25729387 p-tert-Amylphenol increases expression ISO RGD:621303 6480464 4-tert-octylphenol results in increased expression of ATP2B1 mRNA CTD PMID:17011747 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of ATP2B1 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:732984 6480464 Acetaminophen results in increased expression of ATP2B1 mRNA CTD PMID:21420995 , PMID:29067470 phenobarbital affects expression ISO RGD:732984 6480464 Phenobarbital affects the expression of ATP2B1 mRNA CTD PMID:19159669 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of ATP2B1 mRNA CTD PMID:23091169 potassium chromate decreases expression ISO RGD:732984 6480464 potassium chromate(VI) results in decreased expression of ATP2B1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:732984 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATP2B1 mRNA CTD PMID:22079256 potassium dichromate decreases expression ISO RGD:732984 6480464 Potassium Dichromate results in decreased expression of ATP2B1 mRNA CTD PMID:17547211 serpentine asbestos increases expression ISO RGD:732984 6480464 Asbestos, Serpentine results in increased expression of ATP2B1 mRNA CTD PMID:24160326 sodium arsenate decreases expression EXP 6480464 sodium arsenate results in decreased expression of ATP2B1 mRNA CTD PMID:21795629 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of ATP2B1 mRNA CTD PMID:21795629 Soman decreases expression ISO RGD:621303 6480464 Soman results in decreased expression of ATP2B1 mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 [Streptozocin co-treated with bisphenol A] results in increased expression of ATP2B1 mRNA, [Streptozocin co-treated with octylphenol] results in increased expression of ATP2B1 mRNA CTD PMID:29935216 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of ATP2B1 mRNA CTD PMID:29935216 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ATP2B1 mRNA CTD PMID:21641980 tamibarotene affects expression ISO RGD:732984 6480464 tamibarotene affects the expression of ATP2B1 mRNA CTD PMID:15498508 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of ATP2B1 mRNA CTD PMID:17555576 tert-butyl hydroperoxide increases expression ISO RGD:732984 6480464 tert-Butylhydroperoxide results in increased expression of ATP2B1 mRNA CTD PMID:15336504 testosterone multiple interactions ISO RGD:732984 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ATP2B1 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:732984 6480464 Testosterone results in increased expression of ATP2B1 mRNA CTD PMID:21592394 testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of ATP2B1 mRNA CTD PMID:20090667 testosterone enanthate affects expression ISO RGD:732984 6480464 testosterone enanthate affects the expression of ATP2B1 mRNA CTD PMID:17440010 tetrahydropalmatine decreases expression ISO RGD:732984 6480464 tetrahydropalmatine results in decreased expression of ATP2B1 protein CTD PMID:20109541 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of ATP2B1 mRNA CTD PMID:23131501 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP2B1 mRNA CTD PMID:29950665 topotecan multiple interactions ISO RGD:621303 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ATP2B1 mRNA CTD PMID:25729387 trichostatin A decreases expression ISO RGD:732984 6480464 trichostatin A results in decreased expression of ATP2B1 mRNA CTD PMID:24935251 tris(2-butoxyethyl) phosphate affects expression ISO RGD:732984 6480464 tris(2-butoxyethyl) phosphate affects the expression of ATP2B1 mRNA CTD PMID:29024780 tungsten decreases expression EXP 6480464 Tungsten results in decreased expression of ATP2B1 mRNA CTD PMID:30912803 valproic acid affects expression ISO RGD:732984 6480464 Valproic Acid affects the expression of ATP2B1 mRNA CTD PMID:25979313 valproic acid affects splicing ISO RGD:621303 6480464 Valproic Acid affects the splicing of ATP2B1 mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:732984 6480464 Valproic Acid results in increased expression of ATP2B1 mRNA CTD PMID:23179753 more ... vanadium atom increases expression ISO RGD:732984 6480464 Vanadium results in increased expression of ATP2B1 mRNA CTD PMID:19000753 vanadium(0) increases expression ISO RGD:732984 6480464 Vanadium results in increased expression of ATP2B1 mRNA CTD PMID:19000753 vinclozolin affects expression ISO RGD:621303 6480464 vinclozolin affects the expression of ATP2B1 mRNA CTD PMID:19015723 vinclozolin increases expression ISO RGD:621303 6480464 vinclozolin results in increased expression of ATP2B1 mRNA CTD PMID:20566332 zinc oxide decreases expression ISO RGD:732984 6480464 Zinc Oxide analog results in decreased expression of ATP2B1 mRNA, Zinc Oxide analog results in decreased expression of ATP2B1 protein CTD PMID:24060544
Biological Process calcium ion export ISO RGD:621303 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 calcium ion export across plasma membrane ISO UniProtKB:P20020 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 calcium ion transmembrane transport IEA InterPro:IPR006408 , InterPro:IPR030320 2290270 UniProtKB GO_REF:0000002, MGI:MGI:2152098 calcium ion transport TAS 2290270 (MGI:MGI:2667242, PMID:12660151) MGI MGI:MGI:2667242 , PMID:12660151 cellular calcium ion homeostasis IBA FB:FBgn0259214 more ... 2290270 (PMID:21873635) GO_Central PMID:21873635 cellular calcium ion homeostasis IMP 2290270 (MGI:MGI:3703409 more ... UniProt MGI:MGI:3703409 more ... cellular calcium ion homeostasis IBA FB:FBgn0259214 more ... 2290270 (PMID:21873635) GO_Central PMID:21873635 ion transport IEA UniProtKB-KW:KW-0406 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 negative regulation of cytokine production IMP 2290270 (MGI:MGI:6114568, PMID:28827723) UniProt MGI:MGI:6114568 , PMID:28827723 negative regulation of cytosolic calcium ion concentration ISO UniProtKB:P20020 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 negative regulation of cytosolic calcium ion concentration IMP 2290270 (MGI:MGI:5689962, PMID:22311909) UniProt MGI:MGI:5689962 , PMID:22311909 positive regulation of bone mineralization IMP 2290270 (MGI:MGI:5780494, PMID:26392310) UniProt MGI:MGI:5780494 , PMID:26392310 positive regulation of calcium ion transport IMP 2290270 (MGI:MGI:5780494, PMID:26392310) UniProt MGI:MGI:5780494 , PMID:26392310 regulation of blood pressure IMP 2290270 (MGI:MGI:5689962 more ... UniProt MGI:MGI:5689962 more ... regulation of cellular response to insulin stimulus ISO UniProtKB:P20020 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 regulation of cytosolic calcium ion concentration ISO UniProtKB:P20020 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 regulation of cytosolic calcium ion concentration IMP 2290270 (MGI:MGI:6114568 more ... UniProt MGI:MGI:6114568 more ... regulation of cytosolic calcium ion concentration IBA MGI:MGI:105368 more ... 2290270 (PMID:21873635) GO_Central PMID:21873635 regulation of vascular smooth muscle contraction IMP 2290270 (MGI:MGI:6282934, PMID:24805951) UniProt MGI:MGI:6282934 , PMID:24805951 Cellular Component apical part of cell ISO RGD:621303 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 apical plasma membrane ISO RGD:621303 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 basolateral plasma membrane ISO RGD:621303 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 basolateral plasma membrane IDA 2290270 (MGI:MGI:5496297, PMID:23460639) UniProt MGI:MGI:5496297 , PMID:23460639 cell junction IEA UniProtKB-KW:KW-0965 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 cytoplasmic side of plasma membrane ISO RGD:621303 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 dendrite membrane ISO RGD:621303 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 dendritic spine membrane ISO RGD:621303 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 GABA-ergic synapse ISO UniProtKB:P20020 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 GABA-ergic synapse ISO RGD:621303 2290270 MGI GO_REF:0000096, MGI:MGI:4417868 glutamatergic synapse ISO UniProtKB:P20020 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 glutamatergic synapse ISO RGD:621303 2290270 MGI GO_REF:0000096, MGI:MGI:4417868 immunological synapse IDA 2290270 (MGI:MGI:6114568, PMID:28827723) UniProt MGI:MGI:6114568 , PMID:28827723 integral component of membrane IEA InterPro:IPR001757 , InterPro:IPR030320 2290270 UniProtKB GO_REF:0000002, MGI:MGI:2152098 integral component of membrane IEA UniProtKB-KW:KW-0812 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 integral component of plasma membrane TAS 2290270 (MGI:MGI:2667242, PMID:12660151) MGI MGI:MGI:2667242 , PMID:12660151 integral component of presynaptic active zone membrane ISO RGD:621303 2290270 MGI GO_REF:0000096, MGI:MGI:4417868 membrane IEA UniProtKB-KW:KW-0472 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 membrane IEA InterPro:IPR006408 2290270 UniProtKB GO_REF:0000002, MGI:MGI:2152098 membrane raft ISO RGD:621303 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 neuronal cell body membrane ISO RGD:621303 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 nucleoplasm ISO UniProtKB:P20020 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 nucleus ISO UniProtKB:P20020 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 plasma membrane ISO UniProtKB:P20020 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 synapse IEA UniProtKB-KW:KW-0770 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 Molecular Function ATP binding IEA InterPro:IPR006408 , InterPro:IPR030320 2290270 UniProtKB GO_REF:0000002, MGI:MGI:2152098 ATP binding IEA UniProtKB-KW:KW-0067 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 ATPase activity ISO UniProtKB:P20020 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 calcium ion transmembrane transporter activity ISO UniProtKB:P20020 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 calcium transmembrane transporter activity, phosphorylative mechanism IBA PANTHER:PTN000643812 more ... 2290270 (PMID:21873635) GO_Central PMID:21873635 calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration ISO UniProtKB:P20020 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 calmodulin binding IEA UniProtKB-KW:KW-0112 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 metal ion binding IEA UniProtKB-KW:KW-0479 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 nucleotide binding IEA UniProtKB-KW:KW-0547 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 nucleotide binding IEA InterPro:IPR023299 2290270 UniProtKB GO_REF:0000002, MGI:MGI:2152098 PDZ domain binding ISO RGD:621303 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 PDZ domain binding IBA PANTHER:PTN000643848 more ... 2290270 (PMID:21873635) GO_Central PMID:21873635 protein binding IPI UniProtKB:O54994 , UniProtKB:P70227 2290270 (MGI:MGI:3614746, PMID:16352659) MGI MGI:MGI:3614746 , PMID:16352659 protein binding IPI UniProtKB:P97300 2290270 (MGI:MGI:6114568, PMID:28827723) UniProt MGI:MGI:6114568 , PMID:28827723 protein binding IPI UniProtKB:P48193 2290270 (MGI:MGI:5496297, PMID:23460639) UniProt MGI:MGI:5496297 , PMID:23460639
Gene-Chemical Interaction Annotations
